BB Biotech AG
BION
Rank in Stocks
#4507
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Share Price
$61.40
Last synced: 2026-10-21
Market Cap
$3.39B
Change (1 day)
-5.95%
Change (1 year)
25.48%
Country
CH
Trade BB Biotech AG (BION)
Category
Financial Services
Stock price history for BB Biotech AG (BION)
Highest end of day price: $64.01 on 2026-10-01
Lowest end of day price: $15.30 on 2000-01-01
Lowest end of day price: $15.30 on 2000-01-01
Stock price history of BB Biotech AG from 2000 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 6.35% |
| 2025 | 38.69% |
| 2024 | -11.18% |
| 2023 | -24.95% |
| 2022 | -25.80% |
| 2021 | 2.69% |
| 2020 | 17.40% |
| 2019 | 11.01% |
| 2018 | -6.61% |
| 2017 | 23.80% |
| 2016 | -7.89% |
| 2015 | 22.59% |
| 2014 | 52.76% |
| 2013 | 62.77% |
| 2012 | 49.65% |
| 2011 | 1.37% |
| 2010 | -14.60% |
| 2009 | 29.73% |
| 2008 | -26.26% |
| 2007 | 3.29% |
| 2006 | 23.76% |
| 2005 | 1.84% |
| 2004 | 19.32% |
| 2003 | 21.32% |
| 2002 | -43.88% |
| 2001 | -30.37% |
| 2000 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $1.15K | 1.58% |
US
|
|
| $41.51 | 25.51% |
SE
|
|
| $109.74 | -32.14% |
US
|
|
| $89.85 | -27.13% |
US
|
|
| $46.03 | -14.74% |
US
|
